ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,123Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 3593

$963K Total Retail Price of All Prescriptions

Rank: 143 out of 3593

1,616 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,616 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 1,616 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 23,650 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,248 991 1 5
LOVASTATIN 1,190 1,019 2 20
SIMVASTATIN 1,121 989 3 1
LEVOTHYROXINE SODIUM 1,065 895 4 4
AMLODIPINE BESYLATE 961 834 5 3
LISINOPRIL 859 732 6 2
METFORMIN HCL 858 691 7 6
PRAVASTATIN SODIUM 791 587 8 13
BENAZEPRIL HCL 763 624 9 69
HYDROCODONE-ACETAMINOPHEN 679 440 S3 10 7
METOPROLOL TARTRATE 634 541 11 8
MELOXICAM 631 522 12 29
HYDROCHLOROTHIAZIDE 554 487 13 10
FENOFIBRATE 519 358 14 39
FUROSEMIDE 501 452 15 9
GABAPENTIN 488 368 16 16
ATENOLOL 478 398 17 11
ATORVASTATIN CALCIUM 394 314 18 15
ALENDRONATE SODIUM 381 377 19 22
CLONIDINE HCL 380 279 20 41
GLIPIZIDE 335 291 21 40
TRAMADOL HCL 334 250 22 17
CARVEDILOL 310 257 23 23
FLUTICASONE PROPIONATE 292 181 24 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 264 249 25 26
GLYBURIDE 261 237 R 26 55
ZOLPIDEM TARTRATE 250 159 27 12
METOPROLOL SUCCINATE 249 202 28 19
ALLOPURINOL 236 207 29 35
GEMFIBROZIL 233 180 30 88
CITALOPRAM HBR 232 143 31 25
WARFARIN SODIUM 231 201 32 18
DOXAZOSIN MESYLATE 221 209 33 63
TRAZODONE HCL 219 117 34 53
PAROXETINE HCL 217 137 35 62
TIZANIDINE HCL 215 141 36 120
LOSARTAN POTASSIUM 205 172 37 14
RANITIDINE HCL 187 125 38 27
NIFEDIPINE ER 185 177 39 75
OXYBUTYNIN CHLORIDE 184 154 40 104
VENTOLIN HFA 182 109 41 80
TRIAMTERENE-HCTZ 172 142 42 66
POTASSIUM CHLORIDE 167 132 43 24
CLOPIDOGREL 164 127 44 30
FLUOXETINE HCL 162 116 45 60
ISOSORBIDE MONONITRATE ER 160 139 46 61
GLIMEPIRIDE 159 115 47 44
SPIRONOLACTONE 159 135 47 86
DONEPEZIL HCL 158 155 49 31
LIPITOR 156 126 50 136
AMITRIPTYLINE HCL 149 74 R 51 90
ENALAPRIL MALEATE 143 113 52 38
CLOTRIMAZOLE-BETAMETHASONE 141 120 53 94
PANTOPRAZOLE SODIUM 136 112 54 45
TAMSULOSIN HCL 135 118 55 33
ADVAIR DISKUS 134 62 56 47
PREDNISONE 131 100 57 49
BUSPIRONE HCL 129 102 58 156
IBUPROFEN 123 85 59 43
ETODOLAC 122 102 60 247
GLIPIZIDE ER 119 108 61 101
DIGOXIN 116 79 62 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 115 93 63 102
OXYBUTYNIN CHLORIDE ER 113 94 64 175
MECLIZINE HCL 110 101 65 96
AZITHROMYCIN 108 70 66 34
NAMENDA 103 103 67 50
NAPROXEN 102 73 68 68
PLAVIX 100 89 69 42
CIPROFLOXACIN HCL 99 73 70 52
CYCLOBENZAPRINE HCL 97 26 R 71 72
FINASTERIDE 96 88 72 79
VERAPAMIL ER 95 86 73 99
LANTUS 92 65 74 57
HYDRALAZINE HCL 91 65 75 107
BUPROPION HCL SR 89 65 76 207
TERAZOSIN HCL 88 84 77 115
SERTRALINE HCL 87 71 78 28
AMLODIPINE BESYLATE-BENAZEPRIL 86 57 79 65
THEOPHYLLINE ANHYDROUS 83 71 80 286
CAPTOPRIL 79 75 81 213
PROPRANOLOL HCL 78 62 82 181
TRIAMCINOLONE ACETONIDE 77 58 83 119
ESTRADIOL 77 59 R 83 174
LANTUS SOLOSTAR 75 33 85 122
BUMETANIDE 74 51 86 148
INSULIN SYRINGE 72 50 87 91
PHENYTOIN SODIUM EXTENDED 70 50 88 165
OXYCODONE-ACETAMINOPHEN 69 36 S2 89 93
METHOCARBAMOL 68 36 R 90 185
DILTIAZEM ER 68 58 90 194
ACTOS 66 61 92 133
METOCLOPRAMIDE HCL 65 53 93 145
METHYLPREDNISOLONE 63 51 94 103
CYMBALTA 62 29 95 73
CRESTOR 60 55 96 21
DOXYCYCLINE HYCLATE 58 45 97 141
SPIRIVA 56 40 98 87
FELODIPINE ER 55 55 99 229
DILTIAZEM 24HR ER 54 50 100 177
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 41 101 201
KLOR-CON M20 51 47 101 139
AMOXICILLIN 51 27 101 128
ZETIA 50 46 104 110
PROAIR HFA 50 23 104 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.